Lower cancer screening rates differ by region, tied to social vulnerability

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPopulations in U.S. counties defined as more vulnerable based on social factors including socioeconomic sta

Updated on: December 18,2023

Lower cancer screening rates differ by region, tied to social vulnerability

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainPopulations in U.S. counties defined as more vulnerable based on social factors including socioeconomic sta

Updated on:December 18,2023

Innovative test that detects complex DNA patterns may improve mesothelioma detection rate in blood

by Susan Murphy,Mayo ClinicStudy design. Our study involved detecting junctions that result from chromosomal rearrangements, insertions and deletions in mesothelioma in Step 1, then designing pr

Updated on: December 02,2024

Innovative test that detects complex DNA patterns may improve mesothelioma detection rate in blood

by Susan Murphy,Mayo ClinicStudy design. Our study involved detecting junctions that result from chromosomal rearrangements, insertions and deletions in mesothelioma in Step 1, then designing pr

Updated on:December 02,2024

Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

by Nicole Fawcett,University of MichiganImmunostaining in a genetically engineered pediatric high grade glioma model harboring the H3-G34R mutation. Tumor cells are shown in green, nuclei in blu

Updated on: December 26,2023

Precision oncology approach shows potential for high grade gliomas harboring a genetic mutation

by Nicole Fawcett,University of MichiganImmunostaining in a genetically engineered pediatric high grade glioma model harboring the H3-G34R mutation. Tumor cells are shown in green, nuclei in blu

Updated on:December 26,2023

New therapeutic strategy for treating a very aggressive form of breast cancer

byCORDISCredit: CC0 Public DomainScientists have identified a new therapeutic strategy for treating a very aggressive form of breast cancer.Triple-negative breast cancer (TNBC) is one of the mos

Updated on: December 18,2023

New therapeutic strategy for treating a very aggressive form of breast cancer

byCORDISCredit: CC0 Public DomainScientists have identified a new therapeutic strategy for treating a very aggressive form of breast cancer.Triple-negative breast cancer (TNBC) is one of the mos

Updated on:December 18,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on: December 26,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on:December 26,2023

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on: July 17,2024

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade ahead

New tool combines evolution and AI to predict prostate cancer recurrence more than a decade aheadbyInstitute of Cancer ResearchStudy design. Credit:Nature Cancer(2024). DOI: 10.1038/

Updated on:July 17,2024

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on: December 22,2023

Saccharin derivatives give cancer cells a not-so-sweet surprise

byAmerican Chemical SocietyCredit: American Chemical SocietySaccharin received a bad rap after studies in the 1970s linked consumption of large amounts of the artificial sweetener to bladder can

Updated on:December 22,2023

Organ transplant does not worsen prostate cancer outcome

(HealthDay)—Among older men with prostate cancer, an organ transplant is associated with higher overall mortality, but not prostate cancer-specific mortality (PCSM), according to a study published onl

Updated on: December 22,2023

Organ transplant does not worsen prostate cancer outcome

(HealthDay)—Among older men with prostate cancer, an organ transplant is associated with higher overall mortality, but not prostate cancer-specific mortality (PCSM), according to a study published onl

Updated on:December 22,2023

New study categorizes and examines four different types of model related to cancerous tumors

by John Stevenson,City University LondonCategories of model and PubMed entries. Credit: Dr Constantino Carlos Reyes AldasoroThe term model is employed quite widely in science and technology.Rese

Updated on: January 07,2024

New study categorizes and examines four different types of model related to cancerous tumors

by John Stevenson,City University LondonCategories of model and PubMed entries. Credit: Dr Constantino Carlos Reyes AldasoroThe term model is employed quite widely in science and technology.Rese

Updated on:January 07,2024

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on: December 26,2023

Adding capivasertib to fulvestrant improves progression-free survival of hormone receptor-positive breast cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainIn patients with hormone receptor (HR)-positive, HER2-negative tumors resistant to aromatase inhibitors, addition of th

Updated on:December 26,2023

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on: December 27,2023

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron

Updated on:December 27,2023

Scientists make cancer breakthrough that could improve immunotherapy success rate

byUniversity of SouthamptonCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-0435University of Southampton scientists have made a breakthrough in understanding why some can

Updated on: December 27,2023

Scientists make cancer breakthrough that could improve immunotherapy success rate

byUniversity of SouthamptonCredit:Cancer Research(2022). DOI: 10.1158/0008-5472.CAN-22-0435University of Southampton scientists have made a breakthrough in understanding why some can

Updated on:December 27,2023